Leprosy: Treatment and management of complications

Mayra B.C. Maymone; Samantha Venkatesh; Melissa Laughter; Rana Abdat; Jeremy Hugh; Mara M. Dacso; P. Narasimha Rao; Barbara M. Stryjewska; Cory A. Dunnick; Robert P. Dellavalle

doi:10.1016/j.jaad.2019.10.138

Leprosy: Treatment and management of complications

Mayra B.C. Maymone, Samantha Venkatesh, Melissa Laughter, Rana Abdat, Jeremy Hugh, Mara M. Dacso, P. Narasimha Rao, Barbara M. Stryjewska, Cory A. Dunnick, Robert P. Dellavalle

Research output: Contribution to journal › Review article › peer-review

49 Scopus citations

Abstract

In the second article in this continuing medical education series, we review the treatment of leprosy, its immunologic reactions, and important concepts, including disease relapse and drug resistance. A fundamental understanding of the treatment options and management of neuropathic sequelae are essential to reduce disease burden and improve patients’ quality of life.

Original language	English (US)
Pages (from-to)	17-30
Number of pages	14
Journal	Journal of the American Academy of Dermatology
Volume	83
Issue number	1
DOIs	https://doi.org/10.1016/j.jaad.2019.10.138
State	Published - Jul 2020
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2020

Keywords

chemoprophylaxis
disease burden
disease relapse
drug resistance
Hansen's disease
immunoprophylaxis
leprosy
leprosy treatment
Lucio phenomenon
National Hansen's Disease Program
prevention
type 1 leprosy reaction
type 2 leprosy reaction

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1016/j.jaad.2019.10.138

Find It

Find It at U of M Libraries

Cite this

@article{e8b2461bdd27463b8e37596a90f0da5e,

title = "Leprosy: Treatment and management of complications",

abstract = "In the second article in this continuing medical education series, we review the treatment of leprosy, its immunologic reactions, and important concepts, including disease relapse and drug resistance. A fundamental understanding of the treatment options and management of neuropathic sequelae are essential to reduce disease burden and improve patients{\textquoteright} quality of life.",

keywords = "chemoprophylaxis, disease burden, disease relapse, drug resistance, Hansen's disease, immunoprophylaxis, leprosy, leprosy treatment, Lucio phenomenon, National Hansen's Disease Program, prevention, type 1 leprosy reaction, type 2 leprosy reaction",

author = "Maymone, {Mayra B.C.} and Samantha Venkatesh and Melissa Laughter and Rana Abdat and Jeremy Hugh and Dacso, {Mara M.} and Rao, {P. Narasimha} and Stryjewska, {Barbara M.} and Dunnick, {Cory A.} and Dellavalle, {Robert P.}",

note = "Publisher Copyright: {\textcopyright} 2020",

year = "2020",

month = jul,

doi = "10.1016/j.jaad.2019.10.138",

language = "English (US)",

volume = "83",

pages = "17--30",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

publisher = "Mosby Inc.",

number = "1",

}

TY - JOUR

T1 - Leprosy

T2 - Treatment and management of complications

AU - Maymone, Mayra B.C.

AU - Venkatesh, Samantha

AU - Laughter, Melissa

AU - Abdat, Rana

AU - Hugh, Jeremy

AU - Dacso, Mara M.

AU - Rao, P. Narasimha

AU - Stryjewska, Barbara M.

AU - Dunnick, Cory A.

AU - Dellavalle, Robert P.

PY - 2020/7

Y1 - 2020/7

N2 - In the second article in this continuing medical education series, we review the treatment of leprosy, its immunologic reactions, and important concepts, including disease relapse and drug resistance. A fundamental understanding of the treatment options and management of neuropathic sequelae are essential to reduce disease burden and improve patients’ quality of life.

AB - In the second article in this continuing medical education series, we review the treatment of leprosy, its immunologic reactions, and important concepts, including disease relapse and drug resistance. A fundamental understanding of the treatment options and management of neuropathic sequelae are essential to reduce disease burden and improve patients’ quality of life.

KW - chemoprophylaxis

KW - disease burden

KW - disease relapse

KW - drug resistance

KW - Hansen's disease

KW - immunoprophylaxis

KW - leprosy

KW - leprosy treatment

KW - Lucio phenomenon

KW - National Hansen's Disease Program

KW - prevention

KW - type 1 leprosy reaction

KW - type 2 leprosy reaction

UR - http://www.scopus.com/inward/record.url?scp=85086160643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85086160643&partnerID=8YFLogxK

U2 - 10.1016/j.jaad.2019.10.138

DO - 10.1016/j.jaad.2019.10.138

M3 - Review article

C2 - 32244016

AN - SCOPUS:85086160643

SN - 0190-9622

VL - 83

SP - 17

EP - 30

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 1

ER -

Leprosy: Treatment and management of complications

Abstract

Bibliographical note

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this